Can Genzyme Lower the Ante in Discovery?
Executive Summary
Genzyme's added what it hopes will be a lower-cost discovery operation to its product-focused business. It's using tracking stock to keep the expenses off Genzyme Corp.'s P&L, and a pragmatic research approach that won't bet everything on a single technological direction. So far the market's not convinced.